Item 8.01 Other Events.
On September 14, 2021, Ortho Clinical Diagnostics Holdings plc (the "Company")
issued a press release announcing the closing (the "Closing") of the previously
announced underwritten secondary offering (the "Offering") of 25,300,000
ordinary shares of the Company, nominal value $0.00001 per share (the "Ordinary
Shares"), held by a selling shareholder affiliated with The Carlyle Group (the
"Selling Shareholder"), which includes the full exercise by the underwriters of
their option to purchase up to 3,300,000 additional Ordinary Shares, at a price
of $17.50 per Ordinary Share. As a result of the Closing, the Company is no
longer a "controlled company" within the meaning of the rules of the NASDAQ
Global Select Market. A copy of this press release is attached as Exhibit 99.1
to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number Description
Press Release issued by Ortho Clinical Diagnostics Holdings plc dated
99.1 September 14, 2021
Cover Page Interactive Data File (embedded within the Inline XBRL
104 document).
1
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses